Abjaude, Walason; Prati, Bruna; Munford, Veridiana; Montenegro, Aline; Lino, Vanesca; Herbster, Suellen; Rabachini, Tatiana; Termini, Lara; Menck, Carlos Frederico Martins; Boccardo, Enrique (2022). ATM Pathway Is Essential for HPV-Positive Human Cervical Cancer-Derived Cell Lines Viability and Proliferation. Pathogens, 11(6), p. 637. MDPI AG 10.3390/pathogens11060637
|
Text
pathogens-11-00637-v3.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (3MB) | Preview |
Infection with some mucosal human papillomavirus (HPV) types is the etiological cause of cervical cancer and of a significant fraction of vaginal, vulvar, anal, penile, and head and neck carcinomas. DNA repair machinery is essential for both HPV replication and tumor cells survival suggesting that cellular DNA repair machinery may play a dual role in HPV biology and pathogenesis. Here, we silenced genes involved in DNA Repair pathways to identify genes that are essential for the survival of HPV-transformed cells. We identified that inhibition of the ATM/CHK2/BRCA1 axis selectively affects the proliferation of cervical cancer-derived cell lines, without altering normal primary human keratinocytes (PHK) growth. Silencing or chemical inhibition of ATM/CHK2 reduced the clonogenic and proliferative capacity of cervical cancer-derived cells. Using PHK transduced with HPV16 oncogenes we observed that the effect of ATM/CHK2 silencing depends on the expression of the oncogene E6 and on its ability to induce p53 degradation. Our results show that inhibition of components of the ATM/CHK2 signaling axis reduces p53-deficient cells proliferation potential, suggesting the existence of a synthetic lethal association between CHK2 and p53. Altogether, we present evidence that synthetic lethality using ATM/CHK2 inhibitors can be exploited to treat cervical cancer and other HPV-associated tumors.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Pharmacology |
UniBE Contributor: |
Rabachini de Almeida, Tatiana |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
2076-0817 |
Publisher: |
MDPI AG |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
27 Jun 2022 10:04 |
Last Modified: |
05 Dec 2022 16:21 |
Publisher DOI: |
10.3390/pathogens11060637 |
PubMed ID: |
35745491 |
Uncontrolled Keywords: |
ATM BRCA1 CHK2 DNA repair HPV synthetic lethality |
BORIS DOI: |
10.48350/170903 |
URI: |
https://boris.unibe.ch/id/eprint/170903 |
Actions (login required)
 |
Edit item |